

CORRECT: Arix investee doses first patient in tumour drug trial


IN BRIEF: Arix doses first patient in tumour-specific drug trial


Arix Bioscience portfolio value falls as stock picks struggle


UK earnings, trading statements calendar - next 7 days


EXECUTIVE CHANGES: TP's interim CEO; National Grid taps Meggitt chief


UK shareholder meetings calendar - next 7 days


IN BRIEF: Arix investee Harpoon presents updated data for HPN424


UK shareholder meetings calendar - next 7 days